HETEROAROMATIC MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA
The present invention relates to a compound according to general formula (I) wherein X represents N or CH; R1 is -CN, (C1-C6)alkyl, (C3-C7)cycloalkyl, (3-7 membered)heterocycloalkyl, (5-6 membered)heteroaryl, (C3-C7)cycloalkyl(C1-C4)alkyl, (3-7 membered)heterocycloalkyl-(C1-C4)alkyl or (5-6 membered...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
18.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a compound according to general formula (I) wherein X represents N or CH; R1 is -CN, (C1-C6)alkyl, (C3-C7)cycloalkyl, (3-7 membered)heterocycloalkyl, (5-6 membered)heteroaryl, (C3-C7)cycloalkyl(C1-C4)alkyl, (3-7 membered)heterocycloalkyl-(C1-C4)alkyl or (5-6 membered)heteroaryl- (C1-C4)alkyl; R2 is halogen, cyano, (C1-C4)alkyl or (C3-C7)cycloalkyl; R3 is halogen, cyano, (C1-C4)alkyl, (C1-C4)haloalkyl or (C3-C7)cycloalkyl; R4 is (C1-C4)alkyl or (C1-C4)haloalkyl; R5 is (C1-C6)alkyl, (C3-C7)cycloalkyl, (C1-C6)alkyl-(C3-C7)cycloalkyl, (C3-C7)cycloalkyl-(C1-C6)alkyl, (3-7 membered)heterocycloalkyl, phenyl, (5-6 membered)heteroaryl or -ORa. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds and to intermediates for preparation of said compounds.
La présente invention concerne des composés selon la formule générale (I) où X représente N ou CH; R1 est -CN, (C1-C6alkyle, (C3-C7 cycloalkyle, (3-7 membre)hétérocycloalkyle, (5-6 membre)hétéroaryle, (C3-C7) cycloalkyle (C1-C4 alkyle, (3-7 membre) hétérocycloalkyle-(C1-C4 alkyle ou (5-6 membre) hétéroaryle-(C1-C4 alkyle; R2 est un halogène, un cyano, (C1-C4 alkyle ou (C3-C7 cycloalkyle; R3 est un halogène, un cyano, (C1-C4 alkyle, (C1-C4 haloalkyle ou (C3-C7) cycloalkyle; R4 est (C1-C4 alkyle ou (C1-C4 haloalkyle; R5 est (C1-C6 alkyle, (C3-C7 cycloalkyle, (C1-C6 alkyle-(C3-C7) cycloalkyle, (C3-C7 cycloalkyle-(C1-C6) alkyle, (3-7 membre) hétérocycloalkyle, phényle, (5-6 membre) hétéroaryle ou ORa. L'invention concerne également lesdits composés pour l'utilisation en thérapie, des compositions pharmaceutiques comprenant ces composés et des produits intermédiaires pour la préparation desdits composés. |
---|---|
Bibliography: | Application Number: WO2017EP67390 |